# Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

> **NCT07561801** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Pentoxifylline
- Contrast Induced Nephropathy
- Chronic Kidney Disease
- Intensive Care Unit

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT07561801
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07561801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07561801, "Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07561801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*